BioAtla Investor Presentation Deck slide image

BioAtla Investor Presentation Deck

CAB-CTLA-4 (BA3071) Confirmed Complete Response - Cervical Cancer 43-year-old female, stage IV cervical cancer HPV+16 positive, post-platinum, taxane, anti-PD1 and anti-VEGF Baseline - March 23, 2023 bicatla 16.45mm "Multiple enlarged mediastinal, paraesophageal, and right hilar lymph nodes..." On Treatment - August 9, 2023 D "No enlarged mediastinal, hilar or axillary lymph nodes are present. There is persistent resolution of previously noted enlarged mediastinal and paraesophageal lymph nodes." BioAtla| Overview 20
View entire presentation